Kontigo Care AB (KONT) AI Stock Analysis

• Market Cap: kr73.68M
• Dividend Yield: N/A
• Average Volume (3M): 42.06K
• Price to Earnings (P/E): 318.2
• Beta (1Y): 0.10
• Revenue Growth: 0.84%
• EPS Growth: -79.94%
• Country: SE
• Employees: 12
• Sector: Healthcare
• Sector Strength: 55
• Industry: Medical - Healthcare Information Services
• EPS (TTM): -0.02
• Shares Outstanding: 35,251,427
• 10 Day Avg. Volume: 16,378
• 30 Day Avg. Volume: 42,060
• PEG Ratio: -0.10
• Price to Book (P/B): 4.61
• Price to Sales (P/S): 0.00
• P/FCF Ratio: -44.89
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0

• Rating: 59 Neutral
• Price Target: kr2.50 ▲(16.28%Upside)

Kontigo Care AB's stock score reflects strong financial performance with robust revenue growth and a healthy balance sheet. However, technical indicators suggest a bearish trend, and the high P/E ratio implies overvaluation, which could limit stock appreciation. The lack of dividend yield also detracts from the stock's appeal. The company faces challenges in managing free cash flow due to high capital expenditures, which will be key for long-term sustainability.

Kontigo Care AB Business Overview & Revenue Model

Company Description

Kontigo Care AB (KONT) is a Swedish company operating in the digital health sector, with a focus on developing innovative e-health solutions. The company's core product is Previct, an evidence-based digital platform designed for addiction treatment and recovery. Previct provides real-time data analysis and insights to healthcare providers, enhancing patient engagement and treatment outcomes.

How the Company Makes Money

Kontigo Care AB generates revenue primarily through the sale and licensing of its Previct platform to healthcare providers, addiction treatment centers, and municipalities. The company employs a subscription-based model, where clients pay recurring fees for access to the platform and its various features. Additionally, Kontigo Care may engage in strategic partnerships and collaborations to expand the reach and effectiveness of its solutions, further contributing to its revenue streams.

Kontigo Care AB Financial Statement Overview

Summary

Kontigo Care AB exhibits strong revenue growth and improved profitability metrics, supported by a healthy balance sheet with low leverage and high equity. While the operating cash flow is strong, negative free cash flow due to high capital expenditures requires attention. Overall, the company is on a positive financial trajectory, though free cash flow management will be crucial for sustaining long-term growth.

Income Statement

Kontigo Care AB has shown consistent revenue growth, with a notable increase from 2023 to 2024. The company has improved its gross profit margin, evidenced by higher gross profit compared to total revenue. Moreover, the net profit margin has turned positive, reflecting improved profitability. However, the EBIT margin remains relatively low, indicating room for operational efficiency improvements.

Balance Sheet

The balance sheet reveals a strong equity base with a high equity ratio, indicating financial stability and low reliance on debt. The debt-to-equity ratio is low, underscoring a conservative approach to leverage. Return on equity has improved, suggesting efficient use of equity to generate profits. Overall, the financial position is robust with ample equity cushion.

Cash Flow

Kontigo Care AB's operating cash flow remains positive, supporting its liquidity position. However, the free cash flow is negative due to significant capital expenditures, which could pose a risk if not managed well. The operating cash flow to net income ratio suggests a healthy cash conversion cycle, but the company needs to focus on improving free cash flow to ensure sustainable growth.

Breakdown
Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement		Total Revenue
30.24M	28.95M	28.43M	24.54M	20.38M
	Gross Profit
40.08M	43.73M	28.24M	24.16M	20.01M
	EBIT
874.00K	504.00K	2.90M	-1.11M	-1.10M
	EBITDA
5.07M	1.79M	4.13M	2.67M	2.20M
	Net Income Common Stockholders
775.00K	212.00K	2.90M	-1.20M	-1.28M
Balance Sheet		Cash, Cash Equivalents and Short-Term Investments
21.86M	9.85M	5.74M	8.48M	4.94M
	Total Assets
67.74M	49.77M	31.39M	29.20M	24.46M
	Total Debt
3.67M	5.95M	0.00	1.08K	539.82K
	Net Debt
-18.19M	-3.90M	-5.74M	-8.48M	-4.40M
	Total Liabilities
15.42M	19.05M	9.98M	10.74M	9.07M
	Stockholders Equity
52.32M	30.72M	21.40M	18.46M	15.40M
Cash Flow		Free Cash Flow
-5.61M	-9.07M	-2.20M	272.26K	248.43K
	Operating Cash Flow
4.61M	5.97M	7.30M	4.61M	3.99M
	Investing Cash Flow
-10.70M	-16.73M	-9.50M	-4.34M	-3.74M
	Financing Cash Flow
18.11M	14.87M	-540.00K	3.27M	-987.76K

Kontigo Care AB Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 2.15
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SE:KONT, the sentiment is Negative. The current price of 2.15 is above the 20-day moving average (MA) of 2.11, below the 50-day MA of 2.24, and below the 200-day MA of 2.52, indicating a bearish trend. The MACD of -0.05 indicates Negative momentum. The RSI at 44.39 is Neutral, neither overbought nor oversold. The STOCH value of 27.08 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for SE:KONT.

Kontigo Care AB Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
KONT	59 Neutral	kr73.68M	318.18	0.25%	―	0.84%	-79.94%
Sector *	54 Neutral	$5.38B	3.31	-45.11%	3.29%	16.82%	0.04%
PILA	40 Underperform	€80.70M	―		―	―	―
BIOSGN	34 Underperform	€136.67M	―	-56.71%	―	―	35.61%
ACTI	32 Underperform	€283.55M	―	-186.40%	―	―	24.47%
AINO	29 Underperform	kr63.42M	―		―	0.10%	41.59%